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Background
Many psychiatric disorders show gender differences in preva-
lence. Recent studies suggest that female patients diagnosed
with anxiety and depression carry more genetic risks related to
attention-deficit hyperactivity disorder (ADHD) compared with
affected males.
Aims
In this register-based study, we aimed to test whether female
patients who received clinical diagnoses of anxiety, depressive,
bipolar and eating disorders are at higher familial risk for ADHD
and other neurodevelopmental disorders, compared with diag-
nosed male patients.
Method
We analysed data from a record-linkage of several Swedish
national registers, including 151 025 sibling pairs from 103 941
unique index individuals diagnosed with anxiety, depressive,
bipolar or eating disorders, as well as data from 646 948 cousin
pairs. We compared the likelihood of having a relative diagnosed
with ADHD/neurodevelopmental disorders in index males and
females.
Results
Female patients with anxiety disorders were more likely than
affected males to have a brother with ADHD (odd ratio (OR) =
1.13, 95% CI 1.05–1.22). Results for broader neurodevelopmental
disorders were similar and were driven by ADHD diagnoses.
Follow-up analyses revealed similar point estimates for several
categories of anxiety disorders, with the strongest effect
observed for agoraphobia (OR = 1.64, 95% CI 1.12–2.39). No sig-
nificant associations were found in individuals with depressive,
bipolar or eating disorders, or in cousins.
Conclusions
These results provide modest support for the possibility that
familial/genetic risks for ADHD may show gender-specific
phenotypic expression. Alternatively, there could be gender-
specific biases in diagnoses of anxiety and ADHD. These factors
could play a small role in the observed gender differences in
prevalence of ADHD and anxiety.
Keywords
Attention deficit hyperactivity disorders; anxiety disorders;
depressive disorders; bipolar affective disorders; eating
disorders.
Copyright and usage
© The Author(s) 2020. Published by Cambridge University Press
on behalf of The Royal College of Psychiatrists. This is an Open
Access article, distributed under the terms of the Creative
Commons Attribution licence (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted re-use, distribu-
tion, and reproduction in anymedium, provided the original work
is properly cited.
Background
Certain psychiatric disorders are diagnosed more commonly in male
patients (for example attention-deficit hyperactivity disorder (ADHD)
and other neurodevelopmental disorders, such as autism),1,2 or in
female patients (for example anxiety, depression, eating disorders
and to a lesser extent also bipolar disorders).3–7 The reasons for
these widespread gender differences in prevalence are unknown.
Not only are psychiatric disorders moderately to highly heritable,
there is also growing evidence of a substantial component of shared
genetic risks across many disorders.8,9 It is plausible that the genetic
liability for psychiatric problems could manifest in a gender-specific
manner, partly explaining the observed prevalence differences.
Indeed, in children diagnosed with anxiety or depression (both
female-biased disorders), girls have on average a higher burden of
common (i.e. polygenic risk) and rare (i.e. copy number variant)
genetic risks implicated in ADHD (a male-biased disorder).10,11
These findings support the possibility of gender-specific manifest-
ation of biological risk, where the same risk variants are associated
with different psychiatric disorders in males (for example ADHD)
and females (for example anxiety/depression). However, these
studies included fewer than 400 affected children, many of whom
were young, not having passed through the risk period for depression,
which limited the generalisability of the results to early-onset anxiety
and depression.
Aims
In the current study, our aim was to examine a much larger popula-
tion sample of children and adults, clinically diagnosed with a wider
range of psychiatric disorders (male-biased: ADHD and other neuro-
developmental disorders; female-biased: anxiety, depressive, bipolar
and eating disorders). We used a different design to that used in
previous research, to test for converging evidence using diverse
approaches with different strengths and limitations. We used infor-
mation from a national population register to define diagnoses
based on diagnostic codes from specialist in-patient and out-patient
records to examine potential gender-specific effects in real-life diag-
nostic practices. We used nationwide data on biological relatives to
define genetic liability for psychiatric disorders based on familial
risk (which encompasses both common and rare inherited variants).
We hypothesised that female patients who have received clinical diag-
noses of anxiety, depressive, bipolar and eating disorders are at higher
familial risk for ADHD and other neurodevelopmental disorders,
compared with male patients who have received these diagnoses.
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Method
Cohort and variable definition
We used a data linkage of several Swedish registers based on each
individual’s personal identification number.12 The linkage was
approved by the regional ethics review board in Stockholm,
Sweden. The requirement for informed consent was waived
because the study was register based and individuals were not per-
sonally identifiable. We used information from the Medical Birth
Register,13 Total Population Register,14 National Patient Register
(NPR),15 Multi-Generation Register16 and Cause of Death
Register.17 We identified all individuals who were living in
Sweden and were born between 1964 and 2008, and had received
an ICD-10 diagnosis in any of the four categories of psychiatric dis-
orders of interest (i.e. anxiety, depressive, bipolar or eating disor-
ders)18 between 1997 and 2013. These dates were selected as the
NPR was launched in 1964, the ICD-10 was in use from 1997 and
follow-up was until the end of 2013, meaning all index individuals
were at least 5 years old. To control for changing diagnostic prac-
tices over time, we only considered diagnoses based on ICD-10
and not previous versions of the ICD for the four diagnostic categor-
ies of interest. Thus, index patients were identified based on avail-
able information from 1997 to 2013, when they were aged
between 5 and 49 years old.
We retained only index individuals with both known biological
parents linked in the Multi-Generation Register and at least one full
sibling (excluding twins) or first cousin born between 1987 and
2008. These dates were selected to capture all relatives who would
have been children during the usage of the ICD-9 (1987–1997)19
and the ICD-10 (1997 onwards) in Sweden and would be at least
5 years old by the end of the available follow-up period. Full siblings
were identified based on having the same biological parents but not
being born in the same month. First cousins were identified based
on having the same maternal or paternal biological grandparents
but not the same parents.
Data on clinical diagnoses were obtained from the Swedish
NPR, which contains information on in-patient psychiatric care
(1987–2013) and specialist out-patient consultations with doctors
(2001–2013). It includes specialist diagnoses according to ICD-9
and ICD-10, with ongoing updates and validation of the NPR.15
The majority of the diagnoses were obtained from only out-patient
consultations (77%) or a combination of in- and out-patient informa-
tion (93.5%). To improve identification of individuals diagnosed with
eating disorders without recorded diagnoses in the NPR, diagnoses
were also obtained from the Cause of Death Register (based on
ICD-10 codes) and the treatment quality registers (based on DSM-
IV criteria)20. See Table 1 for diagnostic definitions.
For primary analyses, specific diagnoses for female-biased psy-
chiatric disorders were collapsed into four binary variables: any
anxiety disorder, any major depressive disorder (MDD), any
bipolar disorder and any eating disorder. This was deemed justifi-
able given the ICD groupings, as well as evidence of diagnostic flu-
idity, comorbidity and shared genetic influences across diagnostic
subtypes.3,21–24 Given that the typical onset of these disorders is
in mid-childhood/early adolescence, we excluded index individuals
who only received diagnoses at a very young age and never again
(anxiety disorder: age <5 years; MDD/bipolar disorders: age <10
years; eating disorders: age <8 years). Using these cut-offs, n = 575
unique index individuals were excluded from sibling-pair analyses
and n = 507 from cousin-pair analyses. We also defined variables
for age at first recorded diagnosis for each disorder category.
Information on presence of ADHD and neurodevelopmental
disorders was also obtained from the NPR for both index indivi-
duals and their relatives (i.e. siblings and cousins). A broader
group of neurodevelopmental disorders was defined as presence
of one or more of the following disorders: ADHD, autism spectrum
disorder, motor disorders, tic disorders, intellectual disability, com-
munication disorders, specific intellectual disorders and dyslexia.
Both ICD-9 and ICD-10 codes were used (see Table 1) to decrease
the false negative rate of exposure to familial risk in index indivi-
duals. Binary variables were derived for ADHD and for ‘any neuro-
developmental disorder’. Any individuals who received diagnoses of
ADHD/neurodevelopmental disorders only prior to age 1 and never
again were assumed to not have ADHD/neurodevelopmental
disorders.
Data analyses
Logistic regression analyses were used to test for an association
between familial risk of ADHD/neurodevelopmental disorders
and the gender of index individuals diagnosed with anxiety disor-
ders, MDD, bipolar disorders or eating disorders. The exposures
were presence of diagnosed: (a) ADHD or (b) any neurodevelop-
mental disorders, in the sibling (coded as absent, 0 and present, 1)
and the dependent variable was the gender of the diagnosed individ-
ual (coded as male, 0 and female, 1). All analyses were stratified by
the gender of the sibling, to prevent confounding from potential
gender-specific diagnostic biases in relatives. These primary ana-
lyses were adjusted for multiple testing using a stringent
Bonferroni correction (0.05/16 tests); the main results are evaluated
against a threshold of P < 0.0031.
As the data included non-independent observations, a sandwich
estimator was used to cluster the observations by family and derive
robust standard errors. The following covariates were included in
analyses: birth year of the index individual, birth year of the relative,
Table 1 Descriptive summary of diagnostic categories
Diagnostic category Details ICD codesa Exclusion criteria
Anxiety disorders Social anxiety, phobias, generalised anxiety, panic disorders,
separation anxiety, other childhood-onset anxiety disorders
F40, F41, F93 Only diagnosed
age <5 years
Major depressive disorders Single and recurrent major depressive disorders F32, F33, F34 Only diagnosed
age <10 years
Bipolar disorders Mania, bipolar affective disorder F30, F31 Only diagnosed
age <10 years
Eating disorders Anorexia nervosa, bulimia nervosa, unspecified eating disorder F50.0–F50.3, F50.9 Only diagnosed
age <8 years
Attention-deficit
hyperactivity disorder
Hyperkinetic disorder 314/F90 Only diagnosed
age <1 year
Neurodevelopmental
disorders
Attention-deficit hyperactivity disorder, autism spectrum disorder,
motor disorders, tic disorders, intellectual disability,
communication disorders, specific learning disorders, dyslexia
314/F90; 299/F84; 315E, 307D/F82,
F984; 307C/F95; 317–319/F70–F79;
315D/F80; 315A/F81; 315B/R48
Only diagnosed
age <1 year
a. ICD-10, except for ADHD/neurodevelopmental disorders where both ICD-9 and ICD-10 were used, and except eating disorders where DSM-IV was also used (see main text for details).
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age at first diagnosis of the disorder of interest (anxiety disorders,
MDD, bipolar or eating disorders) in the index individual, and pres-
ence of comorbid ADHD/neurodevelopmental disorders (depend-
ing on the exposure) in the index individual. All analyses were
run using Stata version 15.1.
Secondary analyses
Follow-up analyses were used to determine whether results for the
broader group of neurodevelopmental disorders differed when
ADHD was not considered as part of this broad group. Next, we
stratified the index individuals based on presence of comorbid
ADHD, to determine whether the results differed in individuals
with comorbid diagnoses (who may have a more complex clinical
presentation and different genetic liability), compared with those
without comorbid ADHD.
For significant primary associations, follow-up analyses tested
whether any specific ICD diagnostic codes were driving observed
association signals.
To test whether the degree of familial relatedness had an impact
on the results, we analysed observations from cousin pairs. Full sib-
lings share on average 50% of their genomes whereas first cousins
share 12.5% of their genomes and siblings share a greater degree
of their environmental exposures than cousins do, so familial
effects are expected to be stronger in siblings.
Sensitivity analyses
Several sensitivity analyses were conducted. First, we used more
stringent diagnostic definitions to exclude index individuals with
only one recorded diagnosis within each category (anxiety disor-
ders, MDD, bipolar and eating disorders). ADHD diagnoses were
also only considered as present if they were diagnosed at least
twice. This allowed us to investigate whether diagnostic uncertainty
could explain the observed results. Second, we excluded all indivi-
duals who were aged <18 years at the end of the follow-up period
(i.e. those born in 1996 or later) to ensure that all individuals had
lived through the main risk period of getting diagnosed with
ADHD. Third, the analyses were repeated including only siblings
who were born in Sweden and still living there by the end of the
follow-up period (end of 2013). Observations from siblings who
had migrated or died were excluded. This was done to account for
possible uncertainty and missing information during the available
follow-up period. See supplementary Table 1 available at https://
doi.org/10.1192/bjo.2020.47 for details of sample sizes after apply-
ing these exclusions.
Results
The primary cohort included a total of 103 941 (64.3% female)
unique index individuals who were affected with at least one of
the female-biased psychiatric disorders of interest and had at least
one full sibling; each sibling pair was treated as one observation,
yielding 151 025 sibling pairs. For the analyses of cousin pairs, the
total sample consisted of 646 948 cousin-pair observations from
171 247 unique index individuals (63.4% female; supplementary
Table 1).
As expected, there were more females in the primary cohort for
each of the diagnostic categories (Table 2), with a female:male ratio
between 1.71 (anxiety disorders) to 13.54 (eating disorders), with a
similar pattern in the set of index individuals in the analysis of
cousins (supplementary Table 1). Although males were on
average older when they were diagnosed with any anxiety disorder
or MDD, this difference was very small (Table 2). Females were
on average older when they were diagnosed with any eating disor-
ders. Age at first diagnosis was included as a covariate in further
analyses.
The four diagnostic categories were frequently comorbid, with
30.9% of the participants receiving a diagnosis from multiple cat-
egories throughout the follow-up period; see supplementary
Table 2. Female patients weremore likely to havemultiple diagnoses
than male patients (odds ratio OR = 1.65, 95% CI 1.60–1.69). The
most common pair of comorbid conditions were anxiety disorders
and MDD, in both genders.
Primary analyses
Table 3 shows the results of the association analyses between the
gender of the diagnosed index individual and presence of a sibling
diagnosed with ADHD or broader neurodevelopmental disorders.
In individuals diagnosed with anxiety disorders, female patients
were more likely than the male patients to have a brother diagnosed
with ADHD (OR = 1.13, 95% CI 1.05–1.22) or neurodevelopmental
disorders (OR = 1.12, 95% CI 1.05–1.19). The point estimates for
these comparisons were a little lower and non-significant after
multiple testing correction in the analyses of sisters (ADHD:
OR = 1.06, , 95% CI 0.96–1.16; neurodevelopmental disorders:
OR = 1.09, 95% CI 1.01–1.18). Although the point estimates were
elevated for the analysis of brothers of individuals with bipolar dis-
orders (ADHD: OR = 1.13, 95% CI 0.94–1.40; neurodevelopmental
disorders: OR = 1.11, 95% CI 0.92–1.33) and sisters of individuals
with eating disorders (ADHD: OR = 1.39, 95% CI 0.92–2.10; neuro-
developmental disorders: OR = 1.33, 95% CI 0.94–1.89), these con-
fidence intervals overlapped with 1. Thus, there were no significant
associations in index individuals with MDD, bipolar disorders or
eating disorders; see Table 3 for details.
Secondary analyses
When the main analyses were repeated for exposure to risk of broad
neurodevelopmental disorders not including ADHD, the effect sizes
decreased, the confidence intervals increased and there were no
associations for any of the diagnostic categories (supplementary
Table 3). Thus, all further analyses focused on just ADHD diagnosis
as the exposure.
Stratifying the index individuals based on presence of comorbid
ADHD yielded significant associations between having a brother
with ADHD and female anxiety in those with comorbid ADHD
(n = 7327, OR = 1.20, 95% CI 1.05–1.37), P = 0.0066], with a
smaller, non-significant effect in those without comorbid ADHD
Table 2 Gender-specific sample sizes and ages at first diagnosis in the sibling analyses
Diagnostic category
Sample of unique index
individuals
Age at first diagnosis,
mean (s.d.)
OR (95% CIs) PFemales Males Female:male ratio Females Males
Anxiety disorders 38 160 22 260 1.71 20.1 (5.1) 20.2 (5.7) 0.99 (0.99–1.00) <0.0001
Major depressive disorders 36 439 21 221 1.72 20.2 (4.8) 20.6 (5.1) 0.98 (0.98–0.98) <0.0001
Bipolar disorders 4899 2365 2.07 22.2 (4.8) 22.4 (5.6) 0.99 (0.98–1.00) 0.13
Eating disorders 15 584 1151 13.54 18.0 (3.9) 16.5 (4.5) 1.12 (1.09–1.15) <0.0001
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(n = 37 544, OR = 1.09, 95% CI 1.00–1.20, P = 0.061). In contrast,
the analysis of sisters with ADHD showed no association with
gender in index individuals with anxiety and comorbid ADHD
(n = 7104, OR = 0.94, 95% CI 0.81–1.10, P = 0.47), yet an association
in those without comorbid ADHD (n = 35 600, OR = 1.14, 95%
CI 1.01–1.29, P = 0.031). No associations were seen for the other
disorders (supplementary Table 4).
The primary association seen in the context of anxiety was fol-
lowed up to determine whether any specific type(s) of anxiety dis-
orders were driving the association signal. Supplementary Table 5
displays detailed numbers for the ICD-10 anxiety categories. The
following ICD codes, each affecting at least 3% of the individuals
with anxiety, were examined: agoraphobia (F40.0), social phobias
(F40.1), panic disorder (F41.0), generalised anxiety disorder
(GAD; F41.1), mixed anxiety and depressive disorder (F41.2) and
unspecified anxiety disorder (F41.9). The latter category was only
considered as present if none of the other categories of anxiety
examined were present. Compared with the primary analyses,
these follow-up analyses showed similar point estimates for
several categories (i.e. agoraphobia, social phobias, panic disorder
and GAD) in the analyses of brothers, albeit the confidence intervals
overlapped with 1 for most categories, except agoraphobia: OR =
1.64, 95% CI 1.12–2.39; see Fig. 1 and supplementary Table 6 for
details.
Table 3 Results of the association between exposure to sibling with attention-deficit hyperactivity disorder (ADHD)/neurodevelopmental disorders and
gender of index individual, stratified by sibling gendera
Diagnostic category, sibling gender nb
ADHD Neurodevelopmental disorders
OR (95% CI) P OR (95% CI) P
Anxiety disorders
Male 44 871 1.13 (1.05–1.22) 0.0017 1.12 (1.05–1.19) 0.00053
Female 42 704 1.06 (0.96–1.16) 0.23 1.09 (1.01–1.18) 0.023
Major depressive disorders
Male 43 165 1.00 (0.93–1.08) 0.98 0.99 (0.93–1.05) 0.72
Female 40 673 1.03 (0.94–1.13) 0.55 1.08 (1.00–1.17) 0.05
Bipolar disorders
Male 5341 1.13 (0.91–1.40) 0.28 1.11 (0.92–1.33) 0.28
Female 5043 1.08 (0.84–1.39) 0.53 1.07 (0.87–1.32) 0.51
Eating disorders
Male 12 124 0.90 (0.66–1.23) 0.52 0.85 (0.66–1.09) 0.19
Female 11 579 1.39 (0.92–2.10) 0.12 1.33 (0.94–1.89) 0.11
a. Gender of the index individual is coded as male, 0 and female, 1. All estimates are obtained from models adjusted for covariates, as described in text. Bonferroni corrected P-value
threshold: P < 0.0031. Results that are significant at this threshold are in bold.
b. Includes all sibling-index pair observations.
2.5
2.0
1.5
**
*
Ef
fe
ct
 (O
R,
 9
5%
 C
Is
) o
f s
ib
lin
g 
A
D
H
D
 o
n 
ge
nd
er
 o
f i
nd
iv
id
ua
l w
ith
 a
nx
ie
ty
1.0
0.5
Al
l
Ag
or
ap
ho
bia
So
cia
l p
ho
bia
s
Gender of sibling
Female
Male
GA
D
Pa
nic
 d
iso
rd
er M
ix
NO
S
Fig. 1 Results of association between exposure to a sibling being diagnosed with attention-deficit hyperactivity disorder and gender of index
individuals with different categories of anxiety disorders.
GAD, generalised anxiety disorder; Mix, mixed anxiety and depressive disorder; NOS, not otherwise specified. The category NOS excludes individuals if diagnosed with any of the
other categories; otherwise the categories are not mutually exclusive. *P < 0.05, **P < 0.01.
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The estimated magnitude of effect sizes for the association
between having a cousin with ADHD and the gender of index indi-
viduals with anxiety were lower than seen in the sibling-pair ana-
lyses and non-significant (OR, , 95% CI 1.00, 95% CI 0.96–1.05).
No other associations were significant in the cousin analyses (sup-
plementary Table 7).
Sensitivity analyses
Sensitivity analyses were used to examine the stability of the results;
see supplementary Table 1 for sample sizes and female:male ratios.
Of note, the exclusions for these analyses were biased towards
excluding more index males (in sensitivity analyses 1 and 2), as evi-
denced by comparing the sample sizes and female:male ratios in
Table 2 and supplementary Table 1.
Supplementary Table 8 displays the results of the sensitivity
analyses aiming to account for diagnostic uncertainty. The esti-
mated association between female anxiety and having a male
sibling with ADHD was lower with a wider confidence interval
than in the primary analysis (OR = 1.05, 95% CI 0.95–1.17).
Restricting the analyses to observations where both individuals
were aged≥18 years old at the end of the follow-up period (74.5% of
the sample of unique index individuals) also decreased this associ-
ation compared with the primary analyses (OR = 1.09, 95% CI
0.99–1.19) (supplementary Table 9). Although the confidence inter-
vals still overlapped with 1 for the association between females with
bipolar disorders and having a brother with ADHD, the point esti-
mate increased slightly when analysing only adults (OR = 1.22, 95%
CI 0.94–1.57), compared with the full analysis (Table 3).
Excluding observations with incomplete information during
follow-up did not substantially affect the results (supplementary
Table 10). The sensitivity analyses did not reveal any consistent pat-
terns of association results in individuals diagnosed with MDD,
bipolar or eating disorders.
Discussion
The aim of this study was to test the hypothesis that female patients
diagnosed with anxiety, depressive, bipolar and eating disorders are
more likely to have a relative with ADHD or another neurodevelop-
mental disorder compared with affected male patients. We found
modest support for this hypothesis in individuals diagnosed with
anxiety disorders. Although the effect sizes in the analyses of broth-
ers of those with bipolar disorders and sisters of those with eating
disorders were similar to those observed for anxiety, they were stat-
istically non-significant, perhaps because of the lower power asso-
ciated with the lower prevalence of these disorders. No
associations were seen for MDD, despite a similar sample size to
that available for anxiety disorders.
The results observed for anxiety are consistent with two studies
of Swedish children, which found that females with anxiety and/or
depression had a higher burden from genetic variants implicated in
ADHD.10,11 Notably, there were relatively few MDD diagnoses in
these previous studies, because of the young sample. In the
current study, we find supporting evidence in adults. Although
non-significant, the point estimates in the sensitivity analyses of
only adults were not that different for anxiety (OR = 1.09; 74.6%
of sample) and MDD (OR = 1.04; 78.1% of sample) and higher for
bipolar disorders (OR = 1.22; 85.1% of sample), suggesting that dif-
ferences in age at diagnosis could explain the discrepant results
observed for anxiety and MDD in the full cohort.
Our non-significant results for MDD are inconsistent with a
recent UK population study of middle-aged adults, which found
weak evidence to suggest that rare neuropsychiatric copy number
variants may be associated with depression in females.25 On the
other hand, another study of this UK population found no gender
interaction with polygenic risk scores for ADHD and risk of
anxiety, MDD and bipolar disorders,26 which is consistent with our
results for MDD and bipolar disorders but inconsistent with the
results for anxiety. Our results suggest that the age of diagnosed indi-
viduals may have an impact on the observation of an association
between familial/genetic risks and gender differences in psychiatric
disorders.
Follow-up analyses for the association between ADHD in broth-
ers and anxiety in females revealed broadly consistent estimates for
several categories of anxiety, albeit only the association in agorapho-
bia was statistically significant. Although agoraphobia typically
onsets in early adulthood, it may be preceded by transient and sub-
threshold childhood anxiety symptoms.3 Further work is needed to
determine whether only certain anxiety subtypes show gender-spe-
cific associations with ADHD risk.
The association in individuals with anxiety was seen for obser-
vations from brothers but not sisters. This may be because sisters are
less likely to be diagnosed with ADHD, therefore, decreasing the
likelihood of observing the same association as seen in the analysis
of brothers. However, in index individuals without comorbid
ADHD, the estimate for the association between ADHD in sisters
and female anxiety increased. In contrast, there was a larger esti-
mated effect of brother’s ADHD on female gender in those with
comorbid ADHD, with a smaller effect in those without ADHD.
This suggests that gender-specific effects may differ depending on
the presence of comorbid diagnoses.
The observed association in anxiety was not significant in the
cousin-pair analyses, despite the larger sample size. We could not
account for the possibility that shared environmental effects or
gene × environment correlations also contributed (for example via dis-
order manifestation or likelihood of clinical referral). However, twin
studies have shown a limited role for shared environmental effects in
ADHD,27 suggesting that genetic factors are likely to be of greater
importance in explaining the familial effect we observed. Thus, the
results imply that in individuals diagnosed with anxiety disorders,
females are more likely to be at familial (likely genetic) risk for
ADHD than males, consistent with previously observed molecular
genetic effects.10,11
One possible interpretation of these results is that there is
gender-specific manifestation of risk factors, where females at
genetic risk for psychiatric problems may be more likely to
develop, or be diagnosed with, anxiety rather than ADHD or both
anxiety and ADHD, whereas at-risk males may be more likely to
have ADHD than anxiety. The results suggest that comorbid
ADHD and anxiety in females may also be linked to familial risk
of ADHD. Although our stratified analyses suggested that the asso-
ciation between brother’s ADHD and female anxiety was somewhat
stronger in individuals with comorbid ADHD, the confidence inter-
vals overlapped with those in individuals without comorbid ADHD
and the opposite pattern was seen for sisters. In previous work,
accounting for parent-reported ADHD symptoms did not explain
the increased ADHD genetic burden in females with anxiety and
depression.10,11
The mechanisms for how different psychopathology could
emerge in males and females are unknown but could potentially
involve hormonal differences and/or gender-specific parenting
and social influences. Alternatively, there could be gender-specific
diagnostic biases in clinical practice, such as diagnostic overshadow-
ing, where females at genetic risk for psychiatric problems who are
presenting with complex psychopathology may be more likely to
receive a diagnosis of anxiety instead of ADHD or both anxiety
and ADHD, whereas males may be more likely to be diagnosed
with ADHD. In this case, females being diagnosed with anxiety
Investigating gender‐specific effects of familial risk for ADHD
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could indeed have symptoms of ADHD that are either beingmissed,
do not meet diagnostic symptom criteria or are only diagnosed later.
Indeed, in the group of index individuals with comorbid anxiety and
ADHD, females were more likely than males to be diagnosed with
anxiety before ADHD (55.9% of females v. 43.5% of males). Also,
this is plausible given that inattentive ADHD symptoms (which
are likely to be less easily identified than hyperactive symptoms)
are more common in females28,29 and the inattentive subtype of
ADHD may be underdiagnosed when following ICD criteria.
Also, the current diagnostic criteria for ICD and DSM are primarily
based on symptoms typically observed in males and may therefore
miss symptoms more characteristic of female ADHD.30,31 It is
notable that in index individuals with comorbid ADHD and
anxiety in our study, females were diagnosed with ADHD later
than males (females: mean 19.2 (s.d. = 5.3) years; males: mean
18.3 (s.d. = 6.4) years; OR = 1.03, 95% CI 1.02–1.03).
To address the possibility of diagnostic biases, we excluded indi-
viduals with possible diagnostic uncertainty. This attenuated the
observed effect, which indicates a likely role for gender-specific
biases in clinical practice, which resolve over time. However, these
stringent diagnostic exclusions also decreased the sample size and
statistical power, which may also contribute to the weaker results.
Thus, we are unable to definitively conclude whether our results
are best accounted for by gender-specific manifestation of risks or
gender biases in clinical practice, but these explanations are not
necessarily mutually exclusive.
Our results examining a broader group of neurodevelopmental
disorders showed that the observed effect was limited to when
ADHDwas included in the definition of neurodevelopmental disor-
ders. This suggests that the results may not apply to neurodevelop-
mental disorders beyond ADHD, despite shared genetic risks
reported across these disorders.9 However, the coverage of several
ICD diagnoses (such as communication disorders, specific intellec-
tual disorders and dyslexia) is incomplete in the register as these
conditions are commonly diagnosed by educational psychologists.
This, together with the lower sample size for neurodevelopmental dis-
orders beyond ADHD may have had an impact on the observed
results. Further work is needed to determine whether the results of
this study extend to a broader range of neurodevelopmental disorders.
Limitations
The results need to be interpreted in light of several limitations. Our
effect sizes are rather modest. Furthermore, despite including all
individuals in Sweden diagnosed with ICD-10 clinical diagnoses
of anxiety disorders, MDD, bipolar and eating disorders, there
were relatively few individuals, particularly males, with bipolar dis-
orders and eating disorders. As a result of the use of real-life clinical
data, we may have missed individuals who are affected with psychi-
atric disorders but do not have a recorded diagnosis in the register;
as such, our results relate to patterns of diagnoses in individuals who
come to clinical attention, who may be the most severely affected.
To minimise the possibility of missing information on ADHD in
relatives, we applied more stringent exclusion criteria, and this
did not substantially have an impact on the results.
Our inclusion and exclusion criteria, particularly for several of the
sensitivity analyses, resulted in more index males being excluded,
which may have had an impact on the representativeness of the
data. Finally, because of the selection of the primary cohort on the
basis of having full siblings, the results are not representative of indi-
viduals with no siblings; therefore, stoppage effects, whichmay operate
when parents do not have further children (for example in the pres-
ence of psychiatric difficulties), could have an important impact that
we were not able to investigate as part of this study design.
Ultimately, a variety of study designs will be needed to determine
whether and to what extent gender-specific manifestation of psychi-
atric risks and gender-specific diagnostic biases may explain the wide-
spread gender differences in prevalence of psychiatric disorders.
Implications
In short, we report that females with diagnosed anxiety are more
likely to have a brother with ADHD, compared with males diag-
nosed with anxiety. This suggests that familial/genetic risk factors
for ADHD may be more likely to manifest as anxiety in females
compared with males. This association between familial risk for
ADHD and gender of the person affected by a psychiatric disorder
does not surpass statistical significance in the context of depression,
bipolar disorders or eating disorders, showing limited support for
gender-specific effects. Our results support previous work by sug-
gesting that gender-specific manifestation of familial/genetic risk
or gender-specific diagnostic biases may play a small role in explain-
ing the gender differences seen in the prevalence of ADHD and
anxiety. Further research using molecular genetic approaches will
be needed to confirm and extend these results. The results highlight
the importance of studying gender differences in prevalence to
better understand psychiatric disorders with a view towards
improving clinical practice to more effectively target interventions
to diagnose and help affected individuals.
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